News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
247,150 Results
Type
Article (7557)
Company Profile (15)
Press Release (239576)
Multimedia
Podcasts (10)
Webinars (2)
Section
Business (74704)
Career Advice (307)
Deals (14808)
Drug Delivery (40)
Drug Development (36923)
Employer Resources (24)
FDA (6512)
Job Trends (4925)
News (122193)
Policy (11700)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (597)
Accelerated approval (29)
ADA (14)
Adcomms (11)
Allergies (96)
Alliances (14843)
ALS (102)
Alzheimer's disease (815)
Antibody-drug conjugate (ADC) (309)
Approvals (6953)
Artificial intelligence (294)
ASCO (182)
Autoimmune disease (224)
Automation (21)
Bankruptcy (149)
Best Places to Work (4607)
BIO (27)
BIOSECURE Act (3)
Biosimilars (90)
Biotechnology (18)
Bladder cancer (150)
Brain cancer (51)
Breast cancer (373)
Cancer (3665)
Cardiovascular disease (238)
Career advice (278)
Career pathing (12)
CAR-T (235)
CDC (13)
Celiac Disease (2)
Cell therapy (544)
Cervical cancer (37)
Clinical research (34845)
Collaboration (905)
Compensation (258)
Complete response letters (39)
COVID-19 (811)
CRISPR (49)
C-suite (488)
Cystic fibrosis (74)
Data (5569)
Decentralized trials (1)
Denatured (6)
Depression (94)
Dermatology (53)
Diabetes (252)
Diagnostics (2544)
Digital health (21)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (136)
Drug pricing (67)
Drug shortages (19)
Duchenne muscular dystrophy (159)
Earnings (36887)
Editorial (24)
Employer branding (1)
Employer resources (20)
Events (34900)
Executive appointments (421)
FDA (9001)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (15)
Frontotemporal dementia (24)
Funding (749)
Gene editing (115)
Generative AI (23)
Gene therapy (357)
GLP-1 (336)
Government (1341)
Grass and pollen (2)
Guidances (310)
Healthcare (6241)
Hematology (111)
HIV (54)
Huntington's disease (22)
IgA nephropathy (73)
Immunology and inflammation (101)
Immuno-oncology (62)
Indications (134)
Infectious disease (974)
Inflammatory bowel disease (109)
Inflation Reduction Act (6)
Influenza (57)
Intellectual property (214)
Interviews (47)
IPO (8126)
IRA (21)
Job creations (573)
Job search strategy (223)
JPM (11)
Kidney cancer (17)
Labor market (17)
Layoffs (53)
Leadership (10)
Legal (2115)
Liver cancer (59)
Longevity (10)
Lung cancer (469)
Lymphoma (306)
Machine learning (25)
Management (7)
Manufacturing (435)
Marketing (3)
MASH (130)
Medical device (4882)
Medtech (4969)
Mergers & acquisitions (7516)
Metabolic disorders (668)
mRNA (64)
Multiple sclerosis (112)
NASH (9)
Neurodegenerative disease (182)
Neuropsychiatric disorders (49)
Neuroscience (1598)
NextGen: Class of 2026 (1506)
Non-profit (731)
Obesity (270)
Opinion (126)
Ovarian cancer (177)
Pain (132)
Pancreatic cancer (239)
Parkinson's disease (163)
Partnered (12)
Patents (405)
Patient recruitment (491)
Peanut (22)
People (15650)
Pharmaceutical (5)
Pharmacy benefit managers (10)
Phase 1 (11194)
Phase 2 (15384)
Phase 3 (11448)
Pipeline (6516)
Policy (94)
Postmarket research (797)
Preclinical (4123)
Press Release (9)
Prostate cancer (192)
Psychedelics (18)
Radiopharmaceuticals (163)
Rare diseases (586)
Real estate (1015)
Recruiting (8)
Regulatory (11252)
Reports (16)
Research institute (545)
Resumes & cover letters (40)
Rett syndrome (37)
RNA editing (10)
RSV (38)
Schizophrenia (103)
Series A (121)
Series B (94)
Service/supplier (1)
Sickle cell disease (63)
Special edition (2)
Spinal muscular atrophy (37)
Sponsored (20)
Startups (695)
Stomach cancer (6)
Supply chain (47)
Tariffs (13)
The Weekly (3)
Vaccines (351)
Venture capital (28)
Weight loss (137)
Women's health (54)
Worklife (5)
Date
Today (52)
Last 7 days (198)
Last 30 days (1035)
Last 365 days (15679)
2026 (8750)
2025 (15064)
2024 (16922)
2023 (19099)
2022 (22240)
2021 (23637)
2020 (21794)
2019 (14440)
2018 (10639)
2017 (11458)
2016 (9548)
2015 (11741)
2014 (8107)
2013 (5877)
2012 (6042)
2011 (6752)
2010 (6218)
Location
Africa (189)
Alabama (38)
Alaska (2)
Arizona (99)
Arkansas (4)
Asia (18748)
Australia (5138)
California (7388)
Canada (2317)
China (789)
Colorado (290)
Connecticut (390)
Delaware (170)
Europe (30735)
Florida (1149)
Georgia (143)
Hawaii (1)
Idaho (7)
Illinois (553)
India (81)
Indiana (264)
Iowa (1)
Japan (328)
Kansas (31)
Kentucky (14)
Louisiana (19)
Maine (49)
Maryland (781)
Massachusetts (4967)
Michigan (124)
Minnesota (264)
Missouri (79)
Montana (12)
Nebraska (9)
Nevada (103)
New Hampshire (47)
New Jersey (2259)
New Mexico (5)
New York (2121)
North Carolina (768)
North Dakota (2)
Northern California (3776)
Ohio (154)
Oklahoma (2)
Oregon (10)
Pennsylvania (1411)
Puerto Rico (13)
Rhode Island (15)
South America (307)
South Carolina (61)
Southern California (3008)
Tennessee (97)
Texas (1173)
United States (25228)
Utah (178)
Vermont (1)
Virginia (194)
Washington D.C. (22)
Washington State (651)
West Virginia (2)
Wisconsin (31)
Wyoming (1)
247,150 Results for "evgen limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) sign Heads of Terms to Advance their global expansion of CAR T-Cell Therapy
May 6, 2026
·
5 min read
STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indications
STALICLA SA today announced the worldwide in-licensing of SFX-01 from Evgen Pharma plc (Evgen) in neurodevelopmental disorders and schizophrenia, with a first indication for a biologically-characterized subgroup of patients with Autism Spectrum Disorder (ASD).
October 10, 2022
·
4 min read
Press Releases
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
June 28, 2026
·
3 min read
Press Releases
Sharps Technology Adopts Limited Duration Stockholder Rights Plan
May 14, 2026
·
4 min read
Press Releases
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
July 13, 2026
·
5 min read
Press Releases
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
June 5, 2026
·
4 min read
Press Releases
YD Bio Limited Reports Full Year 2025 Financial Results
May 1, 2026
·
12 min read
Press Releases
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
July 10, 2026
·
5 min read
Press Releases
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 1, 2025
·
1 min read
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
In this episode of Denatured, you’ll be listening to Jane Hughes, President of R&D and Co-founder of Verdiva Bio, and Jon Rees, CEO and Co-founder of MitoRx Therapeutics. We’ll discuss next-generation obesity solutions tackling GLP-1’s muscle loss and adherence challenges, through innovative muscle preservation, oral administration and combination therapy.
February 19, 2026
·
1 min read
·
Jennifer C. Smith-Parker
1 of 24,715
Next
